Treeline Biosciences

TRIANA Biomedicines

This company develops molecular glue therapeutics for patients with cancer and other diseases using a discovery platform and computational tools.

D3 Bio

This biotechnology company develops precision medicines and oncology therapeutics for patients with cancer and immunological conditions.

Relay Therapeutics

This company develops small molecule medicines for patients with cancer and genetic diseases by using a platform that models protein motion.

Synnovation Therapeutics

This company develops small molecule precision medicines and targeted therapies to treat cancer patients.

Frontier Medicines

This biopharmaceutical company develops small-molecule precision medicines targeting undruggable proteins for patients with cancer and immunological diseases.

Auron Therapeutics

This company develops small-molecule drugs using an AI-powered platform to treat patients with cancer and inflammatory diseases.

Ten63 Therapeutics

This company develops small-molecule drugs for pharmaceutical partners and patients using a generative artificial intelligence and physics-based chemistry platform to treat undruggable protein targets.

Nimbus Therapeutics

This clinical-stage biotechnology company develops small molecule medicines for patients with cancer, immunology, and metabolic diseases using an AI-enhanced computational discovery engine.